Researcher interests: Investigation of genetic and molecular basis of cancer development; study of genes (coding and non-coding) to elucidate pathways for developing rational, effective therapeutic approaches to cancer. Study of WW domain-containing oxidoreductase (WWOX) tumor suppressor gene, inactivated in most common human cancers.
FACULTY / SCHOOL: School of Medicine - IMRIC
DEPARTMENT: Immunology and Cancer Research
Selected Publications
activation of oncogenic super enhancers is coupled with dna repair by rad51 (2019)|
Cell Reports|
Read more
editorial ww domain proteins in signaling cancer growth neural diseases and metabolic disorders (2019)|
Frontiers in Oncology|
Read more
correction biological functions of mir 29b contribute to positive regulation of osteoblast differentiation (2019)|
Journal of Biological Chemistry|
Read more
decoding the link between wwox and p53 in aggressive breast cancer (2019)|
Cell Cycle|
Read more
wwox inhibits metastasis of triple negative breast cancer cells via modulation of mirnas (2019)|
Cancer Research|
Read more
fhit fdxr interaction in the mitochondria modulation of reactive oxygen species generation and apoptosis in cancer cells (2019)|
Cell Death and Disease|
Read more
tcl1a interacts with tp63 and enhances the survival of raji burkitt lymphoma cell line (2018)|
British Journal of Haematology|
Read more
modeling wwox loss of function in vivo what have we learned (2018)|
Frontiers in Oncology|
Read more
somatic loss of wwox is associated with tp53 perturbation in basal like breast cancer (2018)|
Cell Death and Disease|
Read more
microrna 214 promotes hepatic stellate cell activation and liver fibrosis by suppressing sufu expression (2018)|
Cell Death and Disease|
Read more
